(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.59%) $79.73
(1.65%) $2.34
(0.69%) $2 356.40
(0.58%) $28.53
(0.42%) $995.00
(0.07%) $0.928
(-0.04%) $10.86
(0.07%) $0.799
(0.17%) $92.70
Live Chart Being Loaded With Signals
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services...
Stats | |
---|---|
आज की मात्रा | 236 813 |
औसत मात्रा | 1.31M |
बाजार मूल्य | 7.48B |
EPS | INR0 ( 2024-02-13 ) |
अगली कमाई की तारीख | ( INR0 ) 2024-05-27 |
Last Dividend | INR0.0500 ( 2020-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 92.64 |
ATR14 | INR0.0760 (0.23%) |
मात्रा सहसंबंध
Nectar Lifesciences सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Nectar Lifesciences सहसंबंध - मुद्रा/वस्त्र
Nectar Lifesciences वित्तीय
Annual | 2022 |
राजस्व: | INR15.24B |
सकल लाभ: | INR3.64B (23.91 %) |
EPS: | INR-1.080 |
FY | 2022 |
राजस्व: | INR15.24B |
सकल लाभ: | INR3.64B (23.91 %) |
EPS: | INR-1.080 |
FY | 2022 |
राजस्व: | INR16.69B |
सकल लाभ: | INR2.99B (17.94 %) |
EPS: | INR1.120 |
FY | 2021 |
राजस्व: | INR15.43B |
सकल लाभ: | INR2.58B (16.69 %) |
EPS: | INR-3.27 |
Financial Reports:
No articles found.
Nectar Lifesciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.100 | 2006-02-01 |
Last Dividend | INR0.0500 | 2020-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR1.900 | -- |
Avg. Dividend % Per Year | 0.05% | -- |
Score | 1.38 | -- |
Div. Sustainability Score | 1.879 | |
Div.Growth Potential Score | 2.80 | |
Div. Directional Score | 2.34 | -- |
Year | Amount | Yield |
---|---|---|
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0.0500 | 0.19% |
2019 | INR0.0500 | 0.24% |
2020 | INR0.100 | 0.81% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SAGCEM.NS | Dividend Junior | 2023-06-20 | Annually | 18 | 0.28% | |
LSIL.NS | Dividend Junior | 2023-07-17 | Annually | 3 | 0.23% | |
GEOJITFSL.NS | Dividend Knight | 2023-06-30 | Annually | 20 | 2.79% | |
ARVIND.NS | Dividend Junior | 2023-07-21 | Sporadic | 20 | 0.59% | |
THOMASCOOK.NS | Dividend Junior | 2023-08-10 | Sporadic | 18 | 0.15% | |
ORIENTHOT.NS | Dividend Junior | 2023-07-13 | Sporadic | 23 | 0.22% | |
IRFC.NS | Dividend Junior | 2023-09-15 | Annually | 4 | 2.61% | |
CUB.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 0.35% | |
SHREECEM.NS | Dividend Junior | 2023-06-01 | Annually | 23 | 0.25% | |
MAPMYINDIA.NS | Dividend Junior | 2023-08-25 | Annually | 3 | 0.13% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00493 | 1.500 | 9.90 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.00754 | 1.500 | -1.027 | -1.541 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.093 | 1.000 | -0.706 | -0.706 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.43 | 2.00 | 7.29 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.251 | 1.000 | 9.14 | 9.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0553 | 1.000 | -0.893 | -0.893 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.879 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 96.93 | 1.000 | 0.310 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00754 | 2.50 | -0.660 | -1.541 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.722 | 1.500 | 8.52 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0746 | 1.000 | -0.635 | 0 | [0.1 - 0.5] |
Total Score | 2.80 |
Nectar Lifesciences
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं